The 165th Meeting of The Kanto Koushinetsu areain The Japanese Association for Thoracic Surgery

The Japanese Association for Thoracic SurgeryCOI Disclosure

The author has no conflict of interest to disclose with respect

to this presentation.Presenting author: ●● ●●

The 165th Meeting of The Kanto Koushinetsu areain The Japanese Association for Thoracic Surgery

Research funding has been received from ○○○○.

Presenting author: ●● ●●

The Japanese Association for Thoracic SurgeryCOI Disclosure

The 165th Meeting of The Kanto Koushinetsu areain The Japanese Association for Thoracic Surgery

Lecture fees have been received from ○○○○.

Presenting author: ●● ●●

The Japanese Association for Thoracic SurgeryCOI Disclosure

The 165th Meeting of The Kanto Koushinetsu areain The Japanese Association for Thoracic Surgery

Research funding as an advisor has been received from

○○○○.Presenting author: ●● ●●

The Japanese Association for Thoracic SurgeryCOI Disclosure

The 165th Meeting of The Kanto Koushinetsu areain The Japanese Association for Thoracic Surgery

　 Amount Applicable Name of Company Concerned

Exective/advisor

＞ 1,000,000 yen No 　

Stocks＞ 1,000,000 yen profit/ shareholding ＞ 5%

No 　

Patent royalties ＞ 1,000,000 yen No 　

Lecture fees, etc. ＞ 1,000,000 yen No 　

Manuscript fees, etc.

＞ 1,000,000 yen No 　

Research expenses ＞ 2,000,000 yen Yes 　 Xxxx Pharmaceuticals

The Japanese Association for Thoracic Surgery COI Disclosure

Presenting author: ●● ●●